Skip to content
Film Television Auditions – Lifestyle
Author:
Sanofi Winthrop Industrie
Press Release: Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease
May 28, 2026
Press Release: ATS: phase 2 data demonstrate the superiority of efdoralprin alfa over a standard-of-care augmentation therapy in achieving higher fAAT levels in AATD
May 18, 2026
Press Release: Annual General Meeting of April 29, 2026 – Belén Garijo appointed as Director and Chief Executive Officer of Sanofi
April 29, 2026
Press Release: Sanofi successfully prices 2.3 billion of bond issue
April 24, 2026
Press Release: Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses
April 24, 2026
Press Release: Q1 2026: double-digit sales and business EPS growth
April 23, 2026
←
Previous Page
1
2
3